ReviewFrontiers in microbiology2022
Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 49 citations in OpenAlex.
- Article
- Exogenous microbial consortia modulate rhizosphere microbiome and yield of grafted tomato grown in the mediterranean greenhouse.BMC plant biology · 2026Article
- High-load terephthalic acid degradation and diverse bioproduct formation by novel Rhodococcus strains.Biotechnology letters · 2026Article
- Microbial community characterization in semi-hydroponic systems of Starbor kale (Current research in microbial sciences · 2026Article
- Advanced microbial engineering approaches for biodegradation of pharmaceutical pollutants.Biodegradation · 2025Review
- Harnessing Engineered Microbial Consortia for Xenobiotic Bioremediation: Integrating Multi-Omics and AI for Next-Generation Wastewater Treatment.Journal of xenobiotics · 2025Review
- Article
- A Marine-Derived Steroid fromMarine drugs · 2025Article
- Genome Annotation and Catalytic Profile ofGenes · 2025Article
- Benefits of Immobilized Bacteria in Bioremediation of Sites Contaminated with Toxic Organic Compounds.Microorganisms · 2025Review
- Cooperation BetweenMicroorganisms · 2024Article
- Interspecies synergistic interactions mediated by cofactor exchange enhance stress tolerance by inducing biofilm formation.mSystems · 2024Article
- Transformation of Terpenoids and Steroids Using Actinomycetes of the GenusMolecules (Basel, Switzerland) · 2024Review
- Transcriptional dynamics during Rhodococcus erythropolis infection with phage WC1.BMC microbiology · 2024Article
- Editorial: Pharmaceutically active micropollutants - how serious is the problem and is there a microbial way out?Frontiers in microbiology · 2024Article
- Complete genome sequence of a novelFrontiers in genetics · 2024Article
- Isolation and Characterization of the Wastewater Micropollutant Phenacetin-Degrading BacteriumMicroorganisms · 2023Article
- Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.Pharmaceuticals (Basel, Switzerland) · 2023Review
- Special Issue "Microbial Biodegradation and Biotransformation".Microorganisms · 2023Article
- Progressive Biocatalysts for the Treatment of Aqueous Systems Containing Pharmaceutical Pollutants.Life (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Active pharmaceutical ingredients present a substantial risk when they reach the environment and drinking water sources. As a new type of dangerous pollutants with high chemical resistance and pronounced biological effects, they accumulate everywhere, often in significant concentrations (μg/L) in ecological environments, food chains, organs of farm animals and humans, and cause an intense response from the aquatic and soil microbiota.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.